- Home
- SMA vs SUPN Comparison
SMA vs SUPN Comparison
Compare SMA & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMA
- SUPN
- Stock Information
- Founded
- SMA 2013
- SUPN 2005
- Country
- SMA United States
- SUPN United States
- Employees
- SMA N/A
- SUPN N/A
- Industry
- SMA
- SUPN Biotechnology: Pharmaceutical Preparations
- Sector
- SMA
- SUPN Health Care
- Exchange
- SMA NYSE
- SUPN Nasdaq
- Market Cap
- SMA 2.0B
- SUPN 1.8B
- IPO Year
- SMA 2025
- SUPN 2012
- Fundamental
- Price
- SMA $36.26
- SUPN $33.96
- Analyst Decision
- SMA Strong Buy
- SUPN Hold
- Analyst Count
- SMA 7
- SUPN 2
- Target Price
- SMA $39.43
- SUPN $36.00
- AVG Volume (30 Days)
- SMA 1.1M
- SUPN 739.8K
- Earning Date
- SMA 08-07-2025
- SUPN 08-05-2025
- Dividend Yield
- SMA 4.34%
- SUPN N/A
- EPS Growth
- SMA N/A
- SUPN N/A
- EPS
- SMA N/A
- SUPN 1.11
- Revenue
- SMA $235,799,000.00
- SUPN $667,997,000.00
- Revenue This Year
- SMA $66.15
- SUPN N/A
- Revenue Next Year
- SMA $8.99
- SUPN $12.02
- P/E Ratio
- SMA N/A
- SUPN $29.92
- Revenue Growth
- SMA 5.34
- SUPN 11.82
- 52 Week Low
- SMA $29.89
- SUPN $27.05
- 52 Week High
- SMA $37.79
- SUPN $40.28
- Technical
- Relative Strength Index (RSI)
- SMA N/A
- SUPN 66.18
- Support Level
- SMA N/A
- SUPN $32.49
- Resistance Level
- SMA N/A
- SUPN $33.80
- Average True Range (ATR)
- SMA 0.00
- SUPN 0.91
- MACD
- SMA 0.00
- SUPN 0.23
- Stochastic Oscillator
- SMA 0.00
- SUPN 99.37
About SMA SMARTSTOP SELF STORAGE REIT INC
Smartstop Self Storage REIT Inc operates as a real estate investment trust. The trust owns, acquires, and operates self-storage properties. It operates in two segments namely, self-storage operations which generates key revenue, and managed REIT platform business. The investment objective is to focus on investing in self-storage facilities and related self-storage real estate investments that are expected to support sustainable stockholder distributions over the long term.
About SUPN Supernus Pharmaceuticals Inc.
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, and Osmolex ER.